HR 6160
117th Congress
House
Health
Health care costs and insurance
Health care coverage and access
Medicaid
Medicare
Prescription drugs
Access to Rare Indications Act of 2021
Introduced: December 7, 2021
Introduced by:
Matsui, Doris O.
Democratic
· California
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 8, 2021
Referred to the Subcommittee on Health.
Dec 7, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 7, 2021
Introduced in House
Plain-English summary
Access to Rare Indications Act of 2021
This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used in a way that conflicts with approved labels.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
3